Achieving compliance with the EU Falsified Medicines Directive – what you need to know

Effective in Europe from February 2019, EU directive 2011/62/EU, also referred to as EU FMD, aims to reduce counterfeiting of prescription drugs by tracking and tracing the passage of drugs through the entire supply chain.

Under the Directive, all new packs of prescription medicines placed on the market in Europe from February 2019 onwards will have to bear two safety features: a verifiable unique identifier (serialised code) and an anti-tamper device.

One Year to EU FMD: How to Achieve Compliance in Time

Here's a month-by-month break down on how to comply and optimise your pharmaceutical packaging lines before 09 February 2019.

One Year for EU FMD Implementation: A month-by-month guide to compliance

With one year to go for pharmaceutical manufacturers, packaging sites and Marketing Authorisation Holders (MAHs) to achieve compliance with the Falsified Medicines Directive, the team in Crest Solutions have put together this guide to help you meet the deadline. 

Building a space that reflects and inspires our team

Company culture is central to the success of an organisation. A good culture leads to happy people and well-functioning teams. Culture cannot be manipulated or controlled, rather it is a direct result of values that teams within the company share and work by. When there is a set of core values by which everyone works - the results are revolutionary. 

At Crest Solutions, we are big on people. 

We recognise that our success as a leading partner to our customers begins with the success and happiness of our team members.